Cesarean Scar Ectopic Pregnancy Online Course

This course is based on SMFM Consult Series #63: Cesarean Scar Ectopic Pregnancy.  

This course addresses the risk factors and clinical presentation of CSEP, describes how to correctly diagnose CSEP, and presents the current treatment modalities that are used to manage these high-risk pregnancies. After completing the course, the learner should be able to:

1. Describe the clinical presentation of a CSEP.
2. Identify and describe the optimal strategy for diagnosis of CSEP.
3. List 6 ultrasonographic criteria for diagnosis of a CSEP.
4. Explain why expectant management is not recommended for CSEP.
5. List the medical and surgical modalities that are currently recommended to treat  CSEP and describe the risks and benefits of each.
6. Discuss how a CSEP may impact a future pregnancy. 

Continuing Medical Education Credits

The Society for Maternal-Fetal Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This course is designated for a maximum of 3 AMA PRA Category 1 Credits™. Participants must complete all course components and the completion survey to obtain credits.

This course will be available for purchase from April 17, 2025, to April 17, 2027. Registrants will have a full year (365 days) to complete the course from the date of enrollment. 

AIUM

The AMA PRA Category 1 Credits™ from this activity are accepted by the AIUM for practice accreditation in Detailed First-Trimester Ultrasound.

Disclosures

In accordance with the ACCME Standards for Integrity and Independence, SMFM requires that individuals in a position to control the content of an educational activity disclose all financial relationships with any ineligible company within the preceding 24 months. 

The following individuals in control of this course’s content have no relevant financial relationships:

Course Director: 

Christina Buniak, MD, MPH, Massachusetts General Hospital, Boston, MA

Authors:

Christina Han, MD, Geffen School of Medicine, Los Angeles, CA

Audrey Merriam, MD, MS, Faculty, Yale School of Medicine, New Haven, CT

Russell Miller, MD, Columbia University, New York, NY

Alireza Shamshirsaz, MD, Boston Children’s Hospital/Harvard Medical School, Boston, MA

Lynn Simpson, MD, Columbia University Medical Center, New York, NY

Reviewers:

Alison Cahill, MD, MSCI, University of Texas, Austin, TX

Kecia Gaither, MD, NYC Health + Hospitals, Bronx, NY

Rachel Harrison, MD. Advocate Aurora Health, Chicago, IL

Heidi Leftwich, DO, University of Massachusetts, Worcester, MA: Worcester Foundation Grant, COVID-19 Pandemic Fund—research grant

Ahmed Moustafa, MD, University of Texas Medical Center, Houston, TX

Karin Fox, MD, Baylor College of Medicine, Houston, TX

Christian Pettker, MD, Yale University, New Haven, CT

Flint Porter, MD, University of Utah Health, Salt Lake City, UT

Anthony Sciscione, MD, Christiana Care, Wilmington, DE

Eleazar Soto, MD, University of Texas, Houston, TX

Joanne Stone, MD, Mount Sinai Health System, New York, NY

Staff: 

Kathleen Scogna, Associate VP, Online Education, The Society for Maternal-Fetal Medicine, Washington, DC

The following individuals in control of this course’s content have the following relevant financial relationships:

 Authors:

Andrea Edlow, MD, MSc, Massachusetts General Hospital, Boston, MA: Merck Pharmaceuticals, Simons Foundation—research grant; Mirivie, Inc.—consulting fees

Cynthia Gyamfi-Bannerman, MD, MS, University of California, San Diego, CA: Hologic--consulting fees

 Reviewers:

Lorraine Dugoff, MD, University of Pennsylvania, Philadelphia, PA: Labcorp, Natera—research grants

Torri Metz, MD, University of Utah Health, Salt Lake City, UT: Pfizer—research grant 

Luis Pacheco, MD, University of Texas Medical Branch, Galveston, TX: Coagulant Therapeutics—consulting fees

Rupesh Patel, DO, Advocate Health Care, Park Ridge, IL: Billion to One--consulting fees

Sindhu Srinivas, MD, MSCE, University of Pennsylvania, Philadelphia, PA: NIH, Huff Powell & Bailey LLC, Palladium Risk Retention Group—consulting fees 

For this activity, all relevant financial relationships have been mitigated.